Our Team


Stephen Hsu is Vice-President for Research and Professor of Theoretical Physics at Michigan State University. Educated at Caltech and Berkeley, he was a Harvard Junior Fellow and held faculty positions at Yale and the University of Oregon. Hsu was founder and CEO of SafeWeb, a Silicon Valley technology startup acquired by Symantec for $26 million. He is a scientific advisor to BGI and a member of its Cognitive Genomics lab.

Laurent Christian Asker Melchior Tellier is the Chief Executive Officer and Chief Technological Officer, a co-Director of the Cognitive Genomics Lab at BGI, a visiting scholar from the University of Copenhagen Bioinformatics Centre, and entrepreneur founder of a previous 16-employee informatics startup in Denmark. Laurent’s previous work during his 7 years in China is upon next-generation sequencing and cloud computation in a diagnostic context, leading the CGL’s projects in collaboration with Kings College London and Harvard Vision Lab.

Nathan Treff is Chief Scientific Officer and has a long history in reproductive genetic testing. He is adjunct faculty at Rutgers University School of Medicine, where he teaches reproductive genetics. Nathan is the recipient of 2 General Program, 2 SART, and 2 SRBT Prize Paper Awards, and the 2013 New Investigator Award from ASRM. He has published over 90 peer reviewed papers in Reproductive Genetics and serves as a member of the ASRM Research Committee, and Senior Associate Editor of JARG, and Editor of Fertility and Sterility. He holds a PhD in Biochemistry from Washington State University. Was the Director of Molecular Biology at Reproductive Medicine Associates of New Jersey for 11 years.

Katie Plunkett Chief Sales Officer of Genomic Prediction. Katie comes from a background as a Certified Genetic Counselor, with over 20 years’ experience in Clinical Genetics. At Baylor College of Medicine, Katie spent time as a prenatal and pediatric genetic counselor. She ran the Presymptomatic Huntington’s Disease testing program at Baylor for 18 years and continues to be active in the HD community. Most recently, Katie was a Regional Sales Director at GeneDx, overseeing and directing sales operations and holding profit and loss (P&L) accountability for the West/Southwest American region.

© Genomic Prediction, 2019